Inflation takes center stage in the week ahead as Wall Street looks for more clues on Fed rate hikes
A Fitch downgrade weighed on investor sentiment this week, though it was offset by a better-than-expected July jobs report. Source
Read More
Eli Lilly and Co
Obesity drug maker Versanis to be bought by Eli Lilly for $1.9 billion
The deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by
Read More
A.I. enthusiasm drove up stocks this year. Here’s how investors can catch the next opportunity
It's hard for investors who sat on sidelines during the first half's rally to shake off regret. These investors say
Read More
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Patients taking diabetes and weight loss drugs during anesthesia may be at increased risk of serious complications like nausea and
Read More
Aging populations are creating major opportunities, fund manager says. Here’s where he’s investing
Fund manager Dani Saurymper says aging is an investable area today that will become "increasingly more relevant and apparent." Source
Read More
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
For now, Eli Lilly's orforglipron appears to be the top contender in the weight loss pill space due to its
Read More
Eli Lilly’s weight loss drugs trounce sky-high expectations, boosting the stock
The weight loss medication market is shaping up to be a duopoly of Eli Lilly and Novo Nordisk, analysts said.
Read More
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
Obese or overweight patients who took Eli Lilly's retatrutide lost 58 pounds on average, the pharmaceutical company said in a
Read More
Stocks making the biggest moves midday: Overstock, Tesla, Accenture and more
These are the stocks posting the largest moves in midday trading. Source link
Read More